Prosecution Insights
Last updated: November 20, 2026
Application No. 18/885,857

MANUFACTURING METHOD OF MIXED POWDER, MIXED POWDER, POWDER, AND POWDER MEDIUM

Non-Final OA §102§103§112
Filed
Sep 16, 2024
Priority
Mar 30, 2022 — JP 2022-056103 +1 more
Examiner
DAVIS, RUTH A
Art Unit
1699
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Fujifilm Corporation
OA Round
1 (Non-Final)
61%
Grant Probability
Moderate
1-2
OA Rounds
1y 0m
Est. Remaining
92%
With Interview

Examiner Intelligence

Grants 61% of resolved cases
61%
Career Allowance Rate
562 granted / 921 resolved
+1.0% vs TC avg
Strong +31% interview lift
Without
With
+30.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
43 currently pending
Career history
970
Total Applications
across all art units

Statute-Specific Performance

§101
3.8%
-36.2% vs TC avg
§103
36.6%
-3.4% vs TC avg
§102
15.6%
-24.4% vs TC avg
§112
27.3%
-12.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 921 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, claims 1 – 5, 10 – 15 and 17 – 18 in the reply filed on August 18, 2026 is acknowledged. Claims 1 – 18 are pending; claims 6 – 9 and 16 are withdrawn as being drawn to non elected subject matter. Priority Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Information Disclosure Statement The information disclosure statements (IDS) submitted on January 27, 2025 and July 10, 2025 are in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statements are being considered by the examiner. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 11 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 11 is drawn to a method of making a powder, however, is generally confusing because the language is grammatically unclear. In addition, it is unclear if the method requires steps of dissolving in water or if these steps are optional since the claim recites “in a case where” prior to the step. Further, “the tyrosine” lacks proper antecedent basis. Since the claim does not appear to further limit the method of making a powder but is drawn to a method of using a powder, the claim is interpreted as an intended use of the powder made and to not further define the method of making the powder. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1 – 3 and 10 – 13 are rejected under 35 U.S.C. 102a1 and 102a2 as being anticipated by Von Hagen et al. (WO 2017/020986, cited by US 12,359,164). Regarding claims 1 and 12, Von Hagen teaches a method for making a mixed powder, the method comprising dissolving components in water (solvent) to obtain a solution then freeze drying (powdering step of drying) the solution to obtain a mixed powder of components (col.15); wherein the components are a poorly soluble compound such as cystine and carrier compound such as serine, threonine or tryptophan (col.2 line 35 - col.3 line 25 and line 45 – 55). Regarding claims 2 – 3 and 13, the dissolving step includes heating until dissolution (col.15 line 30 – 45). Regarding claims 10 and 11, while Von Hagen does not teach the claimed functional outcomes of the mixed powder when used, these claims are interpreted as intended uses of the mixed powder obtained by the method of making. In this regard, these limitations do not further limit the manufacturing method of a mixed powder. Thus, the reference anticipates the claimed subject matter. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1 – 3, 5, 10 – 13, 15 and 18 are rejected under 35 U.S.C. 103 as being unpatentable over Von Hagen et al. (WO 2017/020986, cited by US 12,359,164). Regarding claims 1 and 12, Von Hagen teaches a method for making a mixed powder, the method comprising dissolving components in water (solvent) to obtain a solution then freeze drying (powdering step of drying) the solution to obtain a mixed powder of components (col.15); wherein the components are a poorly soluble compound such as cystine and carrier compound such as serine, threonine or tryptophan (col.2 line 35 - col.3 line 25 and line 45 – 55). Regarding claims 2 – 3 and 13, the dissolving step includes heating until dissolution (col.15 line 30 – 45). Regarding claims 10 and 11, while Von Hagen does not teach the claimed functional outcomes of the mixed powder when used, these claims are interpreted as intended uses of the mixed powder obtained by the method of making. In this regard, these limitations do not further limit the manufacturing method of a mixed powder. Regarding claims 5, 15 and 18, Von Hagen does not teach the method wherein the ratio of components is as claimed. However, Von Hagen teaches the poorly soluble, or cystine, may be 1 – 50% with the carrier (serine, threonine and/or tryptophan) is 50 – 99%. Thus, Von Hagen teaches the amounts of each component is variable and may be optimized when practicing the methods therein. As such, at the time the claims were filed, one of ordinary skill in the art would have been motivated to optimize the ratio of components as a matter of routine experimentation and with a reasonable expectation for successfully making a mixed powder. Thus, the invention as a whole is prima facie obvious over the references, especially in the absence of evidence to the contrary. Claims 1 – 5, 10 – 15 and 17 – 18 are rejected under 35 U.S.C. 103 as being unpatentable over Von Hagen et al. (WO 2017/020986, cited by US 12,359,164) in view of Von Hagen (US 2019/0256819, cited below as Von Hagen 2019). Regarding claims 1 and 12, Von Hagen teaches a method for making a mixed powder, the method comprising dissolving components in water (solvent) to obtain a solution then freeze drying the solution (powdering step of drying) to obtain a mixed powder of components (col.15); wherein the components are a poorly soluble compound such as cystine and carrier compound such as serine, threonine or tryptophan (col.2 line 35 - col.3 line 25 and line 45 – 55). Regarding claims 2 – 3 and 13, the dissolving step includes heating until dissolution (col.15 line 30 – 45). Regarding claims 10 and 11, while Von Hagen does not teach the claimed functional outcomes of the mixed powder when used, these claims are interpreted as intended uses of the mixed powder obtained by the method of making. In this regard, these limitations do not further limit the manufacturing method of a mixed powder. Regarding claims 4, 14 and 17, Von Hagen does not teach the method wherein the powdering step is carried out by spray drying or heating and decompressing. However, Von Hagen does teach the method wherein the components are lyophilized (powdering step of drying) together to obtain the mixed powder. At the time the claims were filed, spray drying was a well known functional alternative to lyophilization when making mixed powders. In support, Von Hagen 2019 teaches making mixed powder compositions wherein the mixed components are dissolved in solution then powdered by lyophilization or spray drying (0016, 0033, 0054). Therefore, at the time the claims were filed, it would have been obvious to one of ordinary skill in the art to use spray drying as a functional alternative to freeze drying as a matter of routine practice and with a reasonable expectation for successfully making a mixed powder. Regarding claims 5, 15 and 18, Von Hagen does not teach the method wherein the ratio of components is as claimed. However, Von Hagen teaches the poorly soluble, or cystine, may be 1 – 50% with the carrier (serine, threonine and/or tryptophan) is 50 – 99%. Thus, Von Hagen teaches the amounts of each component is variable and may be optimized when practicing the methods therein. As such, at the time the claims were filed, one of ordinary skill in the art would have been motivated to optimize the ratio of components as a matter of routine experimentation and with a reasonable expectation for successfully making a mixed powder. Thus, the invention as a whole is prima facie obvious over the references, especially in the absence of evidence to the contrary. No claims are allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to RUTH A DAVIS whose telephone number is (571)272-0915. The examiner can normally be reached Monday - Friday (8am - 4pm). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kortney Klinkel can be reached at 571-270-5239. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /RUTH A DAVIS/Primary Examiner, Art Unit 1699
Read full office action

Prosecution Timeline

Sep 16, 2024
Application Filed
Nov 04, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778160
Method and Composition For Reducing Pathogens in Pet Food Using Lactic Acid Bacteria
6y 6m to grant Granted Nov 03, 2026
Patent 12774459
TRUNCATED MODIFIED RECOMBINANT ADAMTS13 AND USES THEREOF
3y 6m to grant Granted Oct 27, 2026
Patent 12773431
COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS
3y 2m to grant Granted Oct 27, 2026
Patent 12766045
Auto-Biodegradable Absorbent Articles
3y 9m to grant Granted Oct 20, 2026
Patent 12766224
DECELLULARIZED BIOMATERIAL FROM NON-MAMMALIAN TISSUE
1y 5m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
61%
Grant Probability
92%
With Interview (+30.9%)
3y 2m (~1y 0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 921 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month